ARCA Biopharma Inc (NASDAQ:ABIO)

0.5315
Delayed Data
As of Jun 22
 +0.01 / +1.92%
Today’s Change
0.45
Today|||52-Week Range
2.71
-60.63%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for ARCA Biopharma Inc have a median target of 1.25, with a high estimate of 1.25 and a low estimate of 1.25. The median estimate represents a +135.18% increase from the last price of 0.53.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in ARCA Biopharma Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.22
Sales
$0.00
Reporting Date
Aug 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -10.00%
 
 
 
 
 
 
Growthannually 42.37%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.